Gluten sensitivity in multiple sclerosis: Experimental myth or clinical truth

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 343-349

  Shor, Dana Ben Ami ^a   Barzilai, Ori ^a   Ram, Maya ^a   Izhaky, David ^a   Porat Katz, Bat Sheva ^b   Chapman, Joab ^a   Blank, Miri ^a   Anaya, Juan Manuel ^c   Shoenfeld, Yehuda ^a,d  

^a SHEBA MEDICAL CENTER   (Israel)

^b KAPLAN HOSPITAL   (Israel)

^c UNIVERSIDAD DEL ROSARIO   (Colombia)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoantibodies; Autoimmunity; Gluten sensitivity; Immunoglobulins; Multiple sclerosis

Indexed keywords

GLIADIN ANTIBODY; GLUTEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GLUTEN FREE DIET; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREVALENCE; SENSITIVITY ANALYSIS;

EID: 69949176817     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04620.x     Document Type: Conference Paper

References (41)

1. Compston, A. & A. Coles. 2002. Multiple sclerosis. Lancet 359: 1221-1231.
2. Hohlfeld, R. 1997. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. Brain 120: 865-916.
3. Walsh, E.C., S. Guschwan-McMahon, M.J. Daly, et al. 2003. Genetic analysis of multiple sclerosis. J. Autoimmun. 21: 111-116.
4. Shatin, R. 1964. Multiple sclerosis and geography. New interpretation of epidemiological observations. Neurology 14: 338-344.
5. Reichelt, K.L. & D. Jensen. 2004. IgA antibodies against gliadin and gluten in multiple sclerosis. Acta Neurol. Scand. 110: 239-241.
6. Pengiran Tengah, C.D., R.J. Lock, D.J. Unsworth & A.J. Wills. 2004. Multiple sclerosis and occult gluten sensitivity. Neurology 62: 2326-2327.
7. Jacob, S., M. Zarei, A. Kenton & H. Allroggen. 2005. Gluten sensitivity and neuromyelitis optica: two case reports. J. Neurol. Neurosurg. Psychiatry 76: 1028-1030.
8. Mandler, R.N. 2006. Neuromyelitis optica-Devic's syndrome, update. Autoimmun. Rev. 5: 537-543.
9. Salvatore, S., S. Finazzi, A. Ghezzi, et al. 2004. Multiple sclerosis and celiac disease: is there an increased risk? Mult. Scler. 10: 711-712.
10. Hadjivassiliou, M., A. Gibson, G.A. Davies-Jones, et al. 1996. Does cryptic gluten sensitivity play a part in neurological illness? Lancet 347: 369-371.
11. Hunter, A.L., B.W. Rees & L.T. Jones. 1984. Gluten antibodies in patients with multiple sclerosis. Hum. Nutr. Appl. Nutr. 38: 142-143.
12. Jones, P.E., C. Pallis & T.J. Peters. 1979. Morphological and biochemical findings in jejunal biopsies from patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 42: 402-406.
13. MacDougall, R. 1973. No bed of roses. World Med. 8: 98-99.
14. Matheson, N.A. 1974. Letter: Multiple sclerosis and diet. Lancet 2: 831.
15. Liversedge, L.A. 1977. Treatment and management of multiple sclerosis. Br. Med. Bull. 33: 78-83.
16. Franklin, G.M. & L. Nelson. 2003. Environmental risk factors in multiple sclerosis: causes, triggers, and patient autonomy. Neurology 61: 1032-1034.
17. Ghezzi, A. & M. Zaffaroni. 2001. Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol. Sci. 22(Suppl 2): S117-122.
18. Anheim, M., B. Degos, A. Echaniz-Laguna, et al. 2006. Ataxia associated with gluten sensitivity, myth or reality? Rev. Neurol. (Paris) 162: 214-221.
19. Burk, K., S. Bosch, C.A. Muller, et al. 2001. Sporadic cerebellar ataxia associated with gluten sensitivity. Brain 124: 1013-1019.
20. Pellecchia, M.T., R. Scala, A. Perretti, et al. 1999. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet. Neurology 53: 1606-1608. (Pubitemid 29491969)
21. Pellecchia, M.T., R. Scala, A. Filla, et al. 1999. Idio-pathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J. Neurol. Neu-rosurg. Psychiatry 66: 32-35. (Pubitemid 29101483)
22. Hadjivassiliou, M., R.A. Grunewald, A.K. Chat-topadhyay, et al. 1998. Clinical, radiological, neuro-physiological, and neuropathological characteristics of gluten ataxia. Lancet 352: 1582-1585.
23. Pellecchia, M.T., G. Ambrosio, E. Salvatore, et al. 2002. Possible gluten sensitivity in multiple system atrophy. Neurology 59: 1114-1115.
24. Gobbi, G. 2005. Coeliac disease, epilepsy and cerebral calcifications. Brain Dev. 27: 189-200.
25. Vojdani, A., T. O'Bryan, J.A. Green, et al. 2004. Immune response to dietary proteins, gliadin and cere-bellar peptides in children with autism. Nutr. Neurosci. 7: 151-161.
26. Licastro, F., R.A. Mariani, G. Faldella, et al. 2001. Immune-endocrine status and coeliac disease in children with Down's syndrome: relationships with zinc and cognitive efficiency. Brain Res. Bull. 55: 313-317.
27. Bushara, K.O., M. Nance & C.M. Gomez. 2004. Antigliadin antibodies in Huntington's disease. Neurology 62: 132-133.
28. Hadjivassiliou, M., R.A. Grunewald, M. Lawden, et al. 2001. Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology 56: 385-388.
29. Poser, CM.PD, L. Scheinberg, W.I. McDonald, et al. 1983. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13: 227-231.
30. Sanchez, J.L., L.G. Palacio, A.C. Londono, et al. 2000. Multiple sclerosis: epidemiological-genetic studies in the population of Antioquia, Colombia. Disequilibrium of HLA DQ alpha. Rev. Neurol. 30: 170-173.
31. Barzilai, O., Y. Sherer, M. Ram, et al. 2007. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann. N. Y. Acad. Sci. 1108: 567-577.
32. Shovman, O., B. Gilburd, O. Barzilai, et al. 2005. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann. N.Y. Acad. Sci. 1050: 380-388.
33. Klutts, J.S., R.S. Liao, W.M. Dunne Jr. & A.M. Gronowski. 2004. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immuno-logic status. J. Clin. Microbiol. 42: 4996-5000.
34. Chinnery, P.F., P.J. Reading, D. Milne, et al. 1997. CSF antigliadin antibodies and the Ramsay Hunt syndrome. Neurology 49: 1131-1133.
35. Hadjivassiliou, M., S. Boscolo, G.A. Davies-Jones, et al. 2002. The humoral response in the pathogenesis of gluten ataxia. Neurology 58: 1221-1226.
36. Hadjivassiliou, M., M. Maki, D.S. Sanders, et al. 2006. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology 66: 373-377.
37. Ziemssen, T. & F. Ziemssen. 2005. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune en-cephalomyelitis (EAE). Autoimmun. Rev. 4: 460-467.
38. De Santis, M.L., G.A. Roth & F.A. Cumar. 1992. Cellular immune crossreactivity between myelin basic protein and synapsin in rats with experimental allergic encephalomyelitis. J. Neurosci. Res. 31: 46-51.
39. Hilfiker, S., V.A. Pieribone, A.J. Czernik, et al. 1999. Synapsins as regulators of neurotransmitter release. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354: 269-279.
40. Alaedini, A., H. Okamoto, C. Briani, et al. 2007. Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I. J. Immunol. 178: 6590-6595.
41. De Camilli, P., R. Cameron & P. Greengard. 1983. Synapsin I (protein I), a nerve terminal-specific phos-phoprotein. I. Its general distribution in synapses of the central and peripheral nervous system demonstrated by immunofluorescence in frozen and plastic sections. J. Cell. Biol. 96: 1337-1354.